Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients | Zendy

Xiao-Yu Yang | Zendy; Jun Zhang | Zendy; Xiaoling Yu | Zendy; Guofeng Zheng | Zendy; Fei Zhao | Zendy; Xiaojing Jia | Zendy

Open Access

Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients

Author(s) -

Xiao-Yu Yang,

Jun Zhang,

Xiaoling Yu,

Guofeng Zheng,

Fei Zhao,

Xiaojing Jia

Publication year - 2018

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.158197

Subject(s) - methylation , medicine , lung cancer , stage (stratigraphy) , oncology , confidence interval , relative risk , gastroenterology , cancer , biology , gene , paleontology , biochemistry

The objective was to study the correlation between death-associated protein kinase (DAPK) promoter methylation and the clinicopathological and prognostic features in nonsmall cell lung cancer (NSCLC) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research